Lipoprotein signatures of cholesteryl ester transfer protein and HMG-CoA reductase inhibition

Journal: PLOS Biology

Published: 2019-12-20

DOI: 10.1371/journal.pbio.3000572

Affiliations: 35

Authors: 22

Go to article
Institutions Share
UCL Institute of Cardiovascular Science (ICS), United Kingdom (UK) 0.14
MRC/BHF Cardiovascular Epidemiology Unit (CEU), University of Cambridge, United Kingdom (UK) 0.10
Biocenter Oulu, University of Oulu, Finland 0.10
Faculty of Medicine (FMed), University of Oulu, Finland 0.09
NIHR Blood and Transplant Research Unit in Donor Health and Genomics, United Kingdom (UK) 0.08
National Institute for Health and Welfare (THL), Finland 0.08
Department of Clinical Physiology, TAUH, Finland 0.05
MRC Integrative Epidemiology Unit (IEU), UoB, United Kingdom (UK) 0.04
Turku University Hospital (TYKS), UTU, Finland 0.04
Bristol Medical School: Population Health Sciences, UoB, United Kingdom (UK) 0.03
Homerton College, University of Cambridge, United Kingdom (UK) 0.02
Finnish Cardiovascular Research Center-Tampere, Tampere University, Finland 0.02
Fimlab Laboratories Ltd., Finland 0.02
Faculty of Medicine, UTU, Finland 0.02
Estonian Genome Center, UT, Estonia 0.02
Diabetes and Obesity Research Program, University of Helsinki, Finland 0.02
Research Centre of Applied and Preventive Cardiovascular Medicine (CAPC), UTU, Finland 0.02
Department of Clinical Physiology and Nuclear Medicine, UTU, Finland 0.02
NIHR Oxford Biomedical Research Centre (OxBRC), United Kingdom (UK) 0.01
Oxford Clinical Trial Service Unit and Epidemiological Studies Unit (CTSU), United Kingdom (UK) 0.01
Oxford MRC Population Health Research Unit (MRC PHRU), United Kingdom (UK) 0.01
Center for Life Course Health Research (CLCHR), University of Oulu, Finland 0.01
Oulu University Hospital (OUH), Finland 0.01
MRC-PHE Centre for Environment and Health, United Kingdom (UK) 0.01
Department of Life Sciences, Brunel University London, United Kingdom (UK) 0.01
Wellcome Sanger Institute, United Kingdom (UK) 0.01
BHF Cambridge Centre of Excellence (CRE), University of Cambridge, United Kingdom (UK) 0.01
Department of Medicine, University of Cambridge, United Kingdom (UK) 0.01
Metabolomics Laboratory, UEF, Finland 0.01
School of Pharmacy, UEF, Finland 0.01
Systems Epidemiology Laboratory, Baker IDI, Australia 0.01
Department of Epidemiology and Preventive Medicine (DEPM), Monash University, Australia 0.01
Alfred Hospital, Australia 0.01

Return

Except where otherwise noted © 2021 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER